Evaluating interventions to facilitate opioid agonist treatment access among people who inject drugs in Toronto, Ontario during COVID-19 pandemic restrictions

Author:

Bouck Zachary,Scheim Ayden I.ORCID,Gomes Tara,Ling VickiORCID,Caudarella Alexander,Werb DanORCID

Funder

Ontario Ministry of Health and Long-Term Care

Institute for Clinical Evaluative Sciences

Canadian Institutes of Health Research

Publisher

Elsevier BV

Subject

Health Policy,Medicine (miscellaneous)

Reference44 articles.

1. Changes in methadone take-home dosing before and after COVID-19;Amram;Journal of Substance Abuse Treatment,2021

2. Validation of self-reported opioid agonist treatment among people who inject drugs using prescription dispensation records;Bouck;Epidemiology,2022

3. Management of opioid use disorders: A national clinical practice guideline;Bruneau;Canadian Medical Association Journal,2018

4. Canadian Centre on Substance Use and Addiction. (2020). Impacts of the COVID-19 pandemic on substance use treatment capacity in Canada. https://www.ccsa.ca/sites/default/files/2020-12/CCSA-COVID-19-Impacts-Pandemic-Substance-Use-Treatment-Capacity-Canada-2020-en.pdf.

5. Centre for Addiction and Mental Health. (2021). Opioid agonist therapy: A synthesis of canadian guidelines for treating opioid use disorder. 52.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3